Sector
TradingOpen
₹210Prev. Close
₹206.74Turnover(Lac.)
₹899.78Day's High
₹212Day's Low
₹20552 Week's High
₹211.2552 Week's Low
₹118.15Book Value
₹42.03Face Value
₹10Mkt Cap (₹ Cr.)
222.03P/E
265.05EPS
0.78Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 10.55 | 10.55 | 10.55 | 10.55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 29.99 | 15.81 | 11.87 | 10.84 |
Net Worth | 40.54 | 26.36 | 22.42 | 21.39 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 53.77 | 60.08 | 75.09 | 67.76 |
yoy growth (%) | -10.5 | -19.98 | 10.81 | 5.92 |
Raw materials | -46.15 | -51.08 | -68.66 | -59.9 |
As % of sales | 85.82 | 85.02 | 91.43 | 88.39 |
Employee costs | -1.84 | -1.93 | -2.12 | -2.03 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 1.4 | 0.07 | 1.13 | 1.34 |
Depreciation | -0.42 | -0.43 | -0.26 | -0.25 |
Tax paid | -0.35 | -0.04 | -0.41 | -0.54 |
Working capital | 2.05 | 0.78 | -1.22 | 11.94 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.5 | -19.98 | 10.81 | 5.92 |
Op profit growth | 218.59 | -59.84 | -26.33 | -19.59 |
EBIT growth | 56.8 | -32.1 | -10.16 | 1.6 |
Net profit growth | 3,091.33 | -95.4 | -10.53 | 12.19 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Adani Enterprises Ltd ADANIENT | 2,968.35 | 119.23 | 3,41,019.94 | 602.26 | 0.04 | 7,800.75 | 145.96 |
Aegis Logistics Ltd AEGISLOG | 801.95 | 58.43 | 29,390.99 | 165.41 | 0.39 | 732.13 | 67.87 |
Cello World Ltd CELLO | 916 | 300.23 | 20,358.97 | 16.76 | 0.16 | 259.95 | 65.65 |
Honasa Consumer Ltd HONASA | 493.85 | 124.91 | 16,026.82 | 34.79 | 0 | 498.4 | 34.63 |
Redington Ltd REDINGTON | 190.95 | 14.38 | 14,994.43 | 155.67 | 3.23 | 10,301.59 | 46.35 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Vasani
Whole-time Director
Jagruti Vasani
Executive Director
Dewansh Vasani
Independent Director
Ashvin Jamnadas Ganatra
Independent Director
Manish Bhagwandas Ved
Company Sec. & Compli. Officer
Vishwa Mekhia
Independent Director
Pratik Vikram Jakhelia
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vaishali Pharma Ltd
Summary
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries; of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent ra
Read More
The Vaishali Pharma Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹207.13 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vaishali Pharma Ltd is ₹222.03 Cr. as of 13 Sep ‘24
The PE and PB ratios of Vaishali Pharma Ltd is 265.05 and 5.17 as of 13 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Vaishali Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vaishali Pharma Ltd is ₹118.15 and ₹211.25 as of 13 Sep ‘24
Vaishali Pharma Ltd's CAGR for 5 Years at 48.86%, 3 Years at 76.34%, 1 Year at 67.81%, 6 Month at 42.14%, 3 Month at 33.29% and 1 Month at 31.07%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice